- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/12 - Fused cells, e.g. hybridomas
Patent holdings for IPC class C12N 5/12
Total number of patents in this class: 408
10-year publication summary
|
16
|
24
|
26
|
36
|
19
|
17
|
15
|
3
|
14
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4370 |
12 |
| AVEO Pharmaceuticals, Inc. | 87 |
8 |
| Beth Israel Deaconess Medical Center, Inc. | 864 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2602 |
7 |
| Kyowa Kirin Co., Ltd. | 367 |
6 |
| Genentech, Inc. | 4012 |
5 |
| Board of Regents, The University of Texas System | 5891 |
5 |
| Amgen Fremont Inc. | 22 |
5 |
| Daiichi Sankyo Company, Limited | 1875 |
5 |
| Kyoto University | 2828 |
5 |
| Redcoat Solutions, Inc. | 13 |
5 |
| Amgen Inc. | 4122 |
4 |
| Kagoshima University | 310 |
4 |
| NB Health Laboratory Co., Ltd. | 28 |
4 |
| Trianni, Inc. | 47 |
4 |
| Xiamen University | 537 |
4 |
| Pfizer Inc. | 3396 |
3 |
| ABS Global, Inc. | 134 |
3 |
| Gmax Biopharm LLC. | 32 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
3 |
| Other owners | 306 |